Shuchi Nahar's Weekend Blog!

Impact of COVID-19 on trades, various sectors , consumables, stock market , healthcare system and many more... SHUCHI.P.NAHAR The coronavirus is not only a health crisis of immense proportion—it’s also an imminent restructuring of the global economic order. Here’s how leaders can begin navigating to what’s next. "Millions of workers in these countries are facing the bleak prospect of losing their jobs. Governments are considering and rolling out large stimulus packages to avert a sharp downturn of their economies which could potentially plunge the global economy into a deep recession. In the worst-case scenario, the world economy could contract by 0.9 per cent in 2020," the DESA said, adding that the world economy had contracted by 1.7 per cent during the global financial crisis in 2009. It added that the contraction could be even higher if governments fail to provide income support and help boost consumer spending. For some organizations, near-term sur

Who Will Cry When You Die? - Robin Sharma SHUCHI.P.NAHAR I generally don't read self-help books. But, this one book made me to read more of such books. Thanks to the author Robin Sharma. It didn't really transform my life in overnight, rather, it did allowed me to sit and introspect a bit on what I might be missing in life. This book is something that reverberates in your mind for a long time, leave alone giving you an idea of what's most important. I really loved the title of the book. In a moment you all want to read this book.  Who Will Cry When You Die? . A question that everyone must ask themselves when they are alone and contemplating about life and its oddities. Robin Sharma had clearly articulated in this book, the 101 'Life Principles'. Is it just 101 or much more? To answer this, there are more to what Robin Sharma had tried to give to his readers. The important chapter is the 99th chapter- “Love Your Work”. The reason why this chapter has been

Indian Pharmaceutical Industry Outlook Shuchi.P.Nahar The pharmaceutical sector is at a crossroads. In a heavily disrupted marketplace, characterized by shifting payer attitudes and patient empowerment, neither incremental adjustments nor steady evolution are likely to halt the decline of the traditional pharmaceutical business model. This paper looks ahead to a 2030 scenario to examine the trends revolutionizing the sector trends that we expect to have dramatic impacts.  The Indian pharmaceutical industry has contributed immensely not just to Indian but to global healthcare outcomes. India continues to play a material role in manufacturing various critical, high‐ quality and low‐cost medicines for Indian and global markets. It supplies 50 to 60 % of global demand for many vaccines (including ARVs), 40 % of generics consumed in the US and 25 percent of all the medicines dispensed in the UK . Over the last 5 years, 35 to 38 % of total ANDAs approved (including 25 to 30 percen